Company record
CSL Behring
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about CSL Behring.
Warning letters
-
BiologicsCSL Behring
FDA says CSL Behring's HIZENTRA TV ad overstates protection and plays down risks, misbranding the immune globulin biologic.
Medium